SLS
SELLAS Life Scnc (SLS)
NASDAQ
$8.06-$0.27 (-3.25%)
Price as of Jun 03, 2026 8:00 PM EDT
  • $1.7B
    Market Cap
  • 407.93%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
0
-100.00%
1.0M
-86.84%
Cost of Revenue
0
N/A
0
N/A
0
-100.00%
100,000
-50.00%
Gross Profit
0
N/A
0
N/A
0
-100.00%
900,000
-87.84%
Sales and Marketing Expense
12.3M
-1.33%
12.4M
-10.42%
13.9M
+10.17%
12.6M
+11.15%
Research and Development Expense
-16.0M
-16.10%
-19.1M
-20.46%
-24.0M
-20.69%
-30.3M
+93.11%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
28.3M
-10.28%
31.5M
-16.78%
37.9M
-11.83%
43.0M
+30.57%
Operating Profit
-28.3M
-10.28%
-31.5M
-16.78%
-37.9M
-9.73%
-42.0M
+65.85%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
1.4M
+123.26%
632,000
+19.47%
529,000
-18.49%
649,000
-85.11%
Income before Taxes
-28.3M
-10.28%
-31.5M
-16.78%
-37.9M
-8.31%
-41.3M
+97.27%
Income Taxes
0
N/A
0
N/A
0
N/A
0
+100.00%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-26.9M
-13.01%
-30.9M
-17.30%
-37.3M
-9.59%
-41.3M
+99.53%
Net Income from Continuing Operations Applicable to Common
-26.9M
-13.01%
-30.9M
-17.30%
-37.3M
-9.59%
-41.3M
+99.53%
Basic EPS and Net Income
-0.25
-50.00%
-0.50
-62.69%
-1.34
-37.09%
-2.13
+58.96%
Diluted EPS and Net Income
-0.25
-50.00%
-0.50
-62.69%
-1.34
-37.09%
-2.13
+58.96%
Basic Weighted Average Shares
109.1M
+78.18%
61.2M
+120.33%
27.8M
+43.21%
19.4M
+25.29%
Diluted Weighted Average Shares
109.1M
+78.18%
61.2M
+120.33%
27.8M
+43.21%
19.4M
+25.29%
Balance Sheet
Cash and Cash Equivalents
71.8M
+417.02%
13.9M
+448.85%
2.5M
-85.23%
17.1M
-19.81%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
71.8M
+417.02%
13.9M
+448.85%
2.5M
-85.23%
17.1M
-19.81%
Total Current Assets
75.2M
+360.65%
16.3M
+414.72%
3.2M
-82.14%
17.8M
-22.95%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Assets
78.3M
+303.18%
19.4M
+212.46%
6.2M
-70.31%
20.9M
-20.29%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
7.0M
-26.21%
9.5M
-30.76%
13.7M
-11.47%
15.5M
+211.42%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
457,000
0.00%
457,000
-0.65%
460,000
-19.72%
573,000
-6.07%
Total Liabilities
7.5M
-25.01%
10.0M
-29.79%
14.2M
-11.79%
16.1M
+171.46%
Retained Earnings
-275.0M
+10.83%
-248.1M
+14.21%
-217.2M
+20.76%
-179.9M
+29.80%
Total Stockholders Equity
70.9M
+648.77%
9.5M
+218.67%
-8.0M
-264.42%
4.9M
-76.16%
Total Shares Outstanding
153.1M
+106.96%
74.0M
+130.22%
32.1M
+52.97%
21.0M
+32.15%
Cash Flow
Cash from Operating Activities
-28.4M
-19.81%
-35.4M
+12.71%
-31.4M
+31.92%
-23.8M
-8.50%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
0
+100.00%
-5.5M
+22.22%
-4.5M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
86.3M
+84.56%
46.8M
+109.54%
22.3M
-7.33%
24.1M
+99.43%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
90.00%
-7.57%
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
-4,195.00%
+1,160.46%
Return on Assets
-54.95%
-77.18%
-240.78%
-12.43%
-274.94%
+57.17%
-174.94%
+205.62%
Return on Equity
-66.88%
-98.39%
-4,147.88%
-273.57%
2,389.76%
+829.00%
-327.81%
+282.53%
Revenue Growth
N/A
N/A
N/A
N/A
-100.00%
+15.15%
-86.84%
-128.95%
Current Ratio
10.72
+524.32%
1.72
+643.53%
0.23
-79.82%
1.14
-75.26%
Cash Ratio
10.23
+600.73%
1.46
+692.67%
0.18
-83.31%
1.10
-74.25%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow